Skip to main content
. 2022 Feb 25;9(4):ofac098. doi: 10.1093/ofid/ofac098

Table 6.

Relationship Between D-dimer Features and Clinical Characteristics, COVID-19 Disease Severity and Features at Long-term Follow-up

Abnormal D-dimer >500 ng/mL
(n = 36)
Normal D-dimer ≤500 ng/mL
(n = 80)
P Value
Age, mean (SD), y 72.34 (14.16) 57.2 (12.53) <.001
Never-smoker, % 62.50 61.54 .554
Pulmonary disease, % 32.35 34.72 .495
Body mass index, mean (SD), kg/m2 30.46 (4.23) 30.69 (6.12) .950
Length of hospital stay, median (IQR), d 22 (10–32) 14 (3–25) .070
Peak RALE score, mean (SD) 4.62 (1.98) 3.94 (2.47) .186
Peak D-dimer, median (IQR) 5062 (1800–22 840) 1748 (800–4568) .020
Severe disease, % 57.14 43.75 .131
Features at long-term follow-up (>180 d)
mMRC dyspnea, mean (SD) 1 (0.87) 0.67 (0.59) .066
FEV/FVC, mean (SD), % 74.85 (2.81) 78.98 (1.00) .349
FEV1, mean (SD), % predicted 96 (19.51) 106.97 (18.80) .028
FVC, mean (SD), % predicted 101.22 (25.86) 110.65 (22.44) .208
SpO2, % 96.09 97.04 .018
DLCO, mean (SD), % predicted 71.73 (22.92) 86.36 (20.83) .006
RALE score, mean (SD) 0 (0) 0.01 (0.11) .505

Abbreviations: DLCO, diffusion capacity for carbon monoxide; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; IQR, interquartile range; mMRC, modified Medical Research Council; RALE, Radiographic Assessment of Lung Edema; SpO2, oxygen saturation.